Valuation Genpharmasec Limited
Stocks
ADIRASA
INE861N01036
Medical Equipment, Supplies & Distribution
|
Market Closed -
Bombay S.E.
11:22:27 01/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.070 INR | -4.46% |
|
-6.96% | -18.32% |
Company Valuation: Genpharmasec Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 2,218 | 1,523 | 861 | 1,235 | 1,009 | 431.9 |
| Change | - | -31.34% | -43.45% | 43.41% | -18.31% | -57.18% |
| Enterprise Value (EV) 1 | 2,074 | 1,463 | 855.3 | 1,056 | 999.3 | 680.6 |
| Change | - | -29.46% | -41.55% | 23.46% | -5.36% | -31.89% |
| P/E | 173x | -550x | 77.8x | -545x | 94.5x | 26.9x |
| PBR | 10.7x | 9.91x | 5.62x | 1.85x | 1.61x | 0.65x |
| PEG | - | 5x | -0x | 5x | -0x | 0.6x |
| Capitalization / Revenue | 10.4x | 5.57x | 3.37x | 4.06x | 2.99x | 0.31x |
| EV / Revenue | 9.74x | 5.36x | 3.35x | 3.47x | 2.96x | 0.49x |
| EV / EBITDA | 174x | -281x | 319x | 5,126x | -249x | 89.7x |
| EV / EBIT | 176x | -273x | 344x | 27,075x | -134x | -85.2x |
| EV / FCF | 282x | -33.1x | -19.6x | -36.2x | -110x | -3.28x |
| FCF Yield | 0.35% | -3.02% | -5.1% | -2.76% | -0.91% | -30.5% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 0.0464 | -0.01 | 0.04 | -0.004091 | 0.02 | 0.029 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 213.1 | 273.2 | 255.2 | 304.1 | 337.2 | 1,399 |
| EBITDA 1 | 11.94 | -5.213 | 2.681 | 0.206 | -4.021 | 7.588 |
| EBIT 1 | 11.82 | -5.355 | 2.484 | 0.039 | -7.472 | -7.993 |
| Net income 1 | 12.57 | -2.093 | 11.25 | -1.257 | 12.31 | 16.04 |
| Net Debt 1 | -143.2 | -59.41 | -5.736 | -178.9 | -9.403 | 248.7 |
| Reference price 2 | 8.010 | 5.500 | 3.110 | 2.230 | 1.890 | 0.780 |
| Nbr of stocks (in thousands) | 276,860 | 276,860 | 276,860 | 553,720 | 533,720 | 553,720 |
| Announcement Date | 06/09/21 | 06/09/22 | 01/09/23 | 01/07/24 | 05/09/25 | 07/09/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 6.16M | |
| 27.63x | 3.84x | 14.83x | 2.64% | 169B | |
| 18.25x | 3.37x | 12.04x | 3.26% | 110B | |
| 21.42x | 4.21x | 14.72x | 1.31% | 106B | |
| 25.26x | 2.48x | 10.04x | 2.86% | 73.87B | |
| 16.92x | 0.2x | 12.42x | 0.77% | 58.98B | |
| 29.48x | 7.29x | 18.84x | 1.36% | 51.28B | |
| 34.07x | 3.32x | 11.38x | 2.22% | 48.16B | |
| 35.11x | 8.73x | 24.55x | -.--% | 40.84B | |
| 34.3x | 6.01x | 18.87x | -.--% | 32.21B | |
| Average | 26.94x | 4.38x | 15.30x | 1.6% | 69.02B | |
| Weighted average by Cap. | 25.35x | 3.98x | 14.47x | 1.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ADIRASA Stock
- Valuation Genpharmasec Limited
Select your edition
All financial news and data tailored to specific country editions
